TY - JOUR
T1 - Effect of neuropsychiatric medications on mitochondrial function
T2 - For better or for worse
AU - Emmerzaal, Tim L.
AU - Nijkamp, Gerben
AU - Veldic, Marin
AU - Rahman, Shamima
AU - Andreazza, Ana Cristina
AU - Morava, Eva
AU - Rodenburg, Richard J.
AU - Kozicz, Tamas
N1 - Funding Information:
T.K. and E.M. are supported by the generosity of the Marriott family. A.C.A. is supported by the Mitochondrial Innovation Initiative, MITO2i. S.R. receives grant funding from the National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre .
Funding Information:
T.K. and E.M. are supported by the generosity of the Marriott family. A.C.A. is supported by the Mitochondrial Innovation Initiative, MITO2i. S.R. receives grant funding from the National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre.
Publisher Copyright:
© 2021
PY - 2021/8
Y1 - 2021/8
N2 - Individuals with mitochondrial disease often present with psychopathological comorbidity, and mitochondrial dysfunction has been proposed as the underlying pathobiology in various psychiatric disorders. Several studies have suggested that medications used to treat neuropsychiatric disorders could directly influence mitochondrial function. This review provides a comprehensive overview of the effect of these medications on mitochondrial function. We collected preclinical information on six major groups of antidepressants and other neuropsychiatric medications and found that the majority of these medications either positively influenced mitochondrial function or showed mixed effects. Only amitriptyline, escitalopram, and haloperidol were identified as having exclusively adverse effects on mitochondrial function. In the absence of formal clinical trials, and until such trials are completed, the data from preclinical studies reported and discussed here could inform medication prescribing practices for individuals with psychopathology and impaired mitochondrial function in the underlying pathology.
AB - Individuals with mitochondrial disease often present with psychopathological comorbidity, and mitochondrial dysfunction has been proposed as the underlying pathobiology in various psychiatric disorders. Several studies have suggested that medications used to treat neuropsychiatric disorders could directly influence mitochondrial function. This review provides a comprehensive overview of the effect of these medications on mitochondrial function. We collected preclinical information on six major groups of antidepressants and other neuropsychiatric medications and found that the majority of these medications either positively influenced mitochondrial function or showed mixed effects. Only amitriptyline, escitalopram, and haloperidol were identified as having exclusively adverse effects on mitochondrial function. In the absence of formal clinical trials, and until such trials are completed, the data from preclinical studies reported and discussed here could inform medication prescribing practices for individuals with psychopathology and impaired mitochondrial function in the underlying pathology.
KW - Antidepressive agents
KW - Drugs
KW - Electron transport chain complex proteins
KW - In vivo studies
KW - Mitochondria
UR - http://www.scopus.com/inward/record.url?scp=85107312442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107312442&partnerID=8YFLogxK
U2 - 10.1016/j.neubiorev.2021.05.001
DO - 10.1016/j.neubiorev.2021.05.001
M3 - Review article
C2 - 34000348
AN - SCOPUS:85107312442
SN - 0149-7634
VL - 127
SP - 555
EP - 571
JO - Neuroscience and Biobehavioral Reviews
JF - Neuroscience and Biobehavioral Reviews
ER -